See the DrugPatentWatch profile for Uceris
Uceris is a prescription medication used to treat ulcerative colitis [1]. It is available in tablet and rectal foam formulations [2]. The tablets are designed for oral administration, while the rectal foam is administered directly into the rectum [2].
How does Uceris work?
Uceris, also known by its generic name, budesonide, is a corticosteroid [1]. It works by reducing inflammation in the colon, which is a characteristic of ulcerative colitis [3]. Budesonide is designed to have a topical effect, meaning it acts primarily in the intestines and has less systemic absorption compared to other corticosteroids [3]. This targeted delivery aims to minimize side effects that can occur with oral steroids [3].
What is Uceris used for?
Uceris tablets are indicated for the induction of remission in adults with active, mild to moderate ulcerative colitis [1]. Ulcerative colitis is a chronic inflammatory bowel disease that affects the large intestine [4]. Symptoms can include diarrhea, abdominal pain, rectal bleeding, and weight loss [4]. Uceris aims to reduce these symptoms and bring about a period of remission [1].
What are the potential side effects of Uceris?
Common side effects associated with Uceris tablets can include headache, upper abdominal pain, nausea, vomiting, and changes in mood or behavior [1]. As a corticosteroid, there is also a risk of more serious side effects, although these are generally less common with the extended-release formulation designed for topical action. These can include adrenal suppression, decreased bone mineral density, and effects on growth in pediatric patients [3].
How does Uceris compare to other treatments for ulcerative colitis?
Uceris belongs to the class of corticosteroid medications used to manage inflammation in ulcerative colitis [1]. Other treatments for ulcerative colitis include aminosalicylates (like mesalamine), immunomodulators (like azathioprine), and biologic therapies (like infliximab or adalimumab) [4]. Corticosteroids like Uceris are often used for short-term treatment to induce remission due to potential long-term side effects [3, 4]. Aminosalicylates are typically used for maintenance therapy, while biologics are often reserved for moderate to severe disease or when other treatments fail [4].
When does the patent for Uceris expire?
Information regarding specific patent expiry dates for Uceris can be found on resources like DrugPatentWatch.com [5]. Patents protect a drug from generic competition for a certain period. Once patents expire, generic versions of the drug can become available, potentially leading to lower costs [5].
Can generic versions of Uceris be developed?
The development of generic versions of Uceris, known as budesonide extended-release tablets, is contingent on patent expiry and regulatory approval [5]. If generic budesonide becomes available, it could offer a more affordable treatment option for patients with ulcerative colitis.